Franco Dallegri
Overview
Explore the profile of Franco Dallegri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
2382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vecchie A, Bonaventura A, Carbone F, Maggi D, Ferraiolo A, Carloni B, et al.
Biomed Res Int
. 2020 Mar;
2020:9309121.
PMID: 32219148
Background: Autoantibodies against apolipoprotein A-1 (anti-ApoA-1 IgG) were demonstrated to be associated with cardiovascular outcomes in several inflammatory diseases. As balanced inflammation is critical for uncomplicated pregnancy, we aimed to...
2.
Bonaventura A, Carbone F, Liberale L, Mach F, Roth A, Burger F, et al.
J Cardiovasc Med (Hagerstown)
. 2019 Oct;
21(1):80-82.
PMID: 31567635
No abstract available.
3.
Vecchie A, Montecucco F, Carbone F, Dallegri F, Bonaventura A
Curr Pharm Des
. 2019 Sep;
25(29):3112-3127.
PMID: 31470783
Background: Diabetes is increasing over time, mainly driven by obesity, aging, and urbanization. Classical macro- and microvascular complications represent the final result of a complex interplay involving atherosclerosis at all...
4.
Carbone F, Grossi F, Bonaventura A, Vecchie A, Minetti S, Bardi N, et al.
Clin Exp Metastasis
. 2019 Aug;
36(5):449-456.
PMID: 31376097
Treatment with nivolumab improves survival and response rate in non-small cell lung cancer (NSCLC). Nevertheless, due to its high financial cost, identifying predictors of response to treatment has become an...
5.
Bonaventura A, Grossi F, Carbone F, Vecchie A, Minetti S, Bardi N, et al.
Cancer Immunol Immunother
. 2019 Jul;
68(8):1351-1358.
PMID: 31327024
Monoclonal antibodies targeting PD-1 are used for treating NSCLC. To date, proprotein convertase subtilisin/kexin type 9 (PCSK9) has been poorly investigated in the oncologic field. Here, we aimed at evaluating...
6.
Ferrara D, Montecucco F, Dallegri F, Carbone F
J Cell Physiol
. 2019 May;
234(12):21630-21641.
PMID: 31106419
A growing body of evidence is pointing out the pathophysiological role of fat accumulation in different organs. Ectopic fat depots within heart, liver, skeletal muscle, kidney, and pancreas as well...
7.
Carbone F, Elia E, Casula M, Bonaventura A, Liberale L, Bertolotto M, et al.
Eur J Clin Invest
. 2019 May;
49(8):e13128.
PMID: 31091356
Background: Inflammation, overweight and other cardiovascular risk factors might negatively impact on hypertension remission in metabolic syndrome (MetS), independently of the pharmacological treatment. Here, the potential influence of systemic inflammation...
8.
Bonaventura A, Liberale L, Carbone F, Vecchie A, Bonomi A, Scopinaro N, et al.
Acta Diabetol
. 2019 Apr;
56(7):741-748.
PMID: 30993529
Aims: Metabolic surgery is considered as a therapeutic option for obese patients with type 2 diabetes (T2D). In order to identify novel laboratory variables that could improve the selection of...
9.
Bonaventura A, Montecucco F, Dallegri F, Carbone F, Luscher T, Camici G, et al.
Cardiovasc Res
. 2019 Mar;
115(8):1266-1285.
PMID: 30918936
Neutrophils are the most abundant circulating leucocytes in healthy humans. These cells are central players during acute inflammatory responses, although a growing body of evidence supports a crucial role in...
10.
Carbone F, Dallegri F, Montecucco F, Poggi A, Nobili F, Cacciapaglia F, et al.
Eur J Clin Invest
. 2019 Feb;
49(5):e13089.
PMID: 30767212
Background: Ultrasound evaluation of carotid intima-media thickness (cIMT) has been extensively used for potentially improving cardiovascular (CV) risk stratification in several patients' categories. Subjects with systemic lupus erythematosus (SLE) have...